Log in
NASDAQ:BMRA

Biomerica Stock Forecast, Price & News

$7.10
+0.46 (+6.93 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.58
Now: $7.10
$7.10
50-Day Range
$5.86
MA: $7.45
$9.12
52-Week Range
$2.05
Now: $7.10
$23.39
Volume86,731 shs
Average Volume937,756 shs
Market Capitalization$83.45 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.9
Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It primarily offers its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the point-of-care and in-hospital/clinical laboratories worldwide. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy, which is in clinical studies to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BMRA
CUSIPN/A
Phone949-645-2111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.69 million
Book Value$1.43 per share

Profitability

Net Income$-2,340,000.00

Miscellaneous

Employees54
Market Cap$83.45 million
Next Earnings Date10/21/2020 (Estimated)
OptionableNot Optionable
$7.10
+0.46 (+6.93 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Biomerica (NASDAQ:BMRA) Frequently Asked Questions

How has Biomerica's stock price been impacted by Coronavirus (COVID-19)?

Biomerica's stock was trading at $2.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BMRA stock has increased by 144.8% and is now trading at $7.10.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Biomerica?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biomerica in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Biomerica
.

When is Biomerica's next earnings date?

Biomerica is scheduled to release its next quarterly earnings announcement on Wednesday, October 21st 2020.
View our earnings forecast for Biomerica
.

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) issued its quarterly earnings results on Tuesday, September, 1st. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.03. Biomerica had a negative return on equity of 36.23% and a negative net margin of 34.95%.
View Biomerica's earnings history
.

What price target have analysts set for BMRA?

2 brokerages have issued twelve-month target prices for Biomerica's stock. Their forecasts range from $11.00 to $13.00. On average, they anticipate Biomerica's stock price to reach $12.00 in the next year. This suggests a possible upside of 69.0% from the stock's current price.
View analysts' price targets for Biomerica
.

Are investors shorting Biomerica?

Biomerica saw a increase in short interest in August. As of August 31st, there was short interest totaling 738,300 shares, an increase of 11.3% from the August 15th total of 663,200 shares. Based on an average trading volume of 818,000 shares, the short-interest ratio is currently 0.9 days. Approximately 8.2% of the company's stock are sold short.
View Biomerica's Short Interest
.

Who are some of Biomerica's key competitors?

What other stocks do shareholders of Biomerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomerica investors own include Sorrento Therapeutics (SRNE), Opko Health (OPK), Pfizer (PFE), Zynga (ZNGA), Advanced Micro Devices (AMD), Inovio Pharmaceuticals (INO), Vuzix (VUZI), Vaxart (VXRT), Accenture (ACN) and Akers Biosciences (AKER).

Who are Biomerica's key executives?

Biomerica's management team includes the following people:
  • Mr. Zackary S. Irani, Chairman & CEO (Age 53)
  • Ms. Janet Moore, CFO, Treasurer, Sec. & Director (Age 68)

What is Biomerica's stock symbol?

Biomerica trades on the NASDAQ under the ticker symbol "BMRA."

Who are Biomerica's major shareholders?

Biomerica's stock is owned by a number of retail and institutional investors. Top institutional investors include Heritage Investors Management Corp (0.58%), Perritt Capital Management Inc. (0.21%), Virtu Financial LLC (0.19%) and California Public Employees Retirement System (0.13%).
View institutional ownership trends for Biomerica
.

Which institutional investors are selling Biomerica stock?

BMRA stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc..
View insider buying and selling activity for Biomerica
.

Which institutional investors are buying Biomerica stock?

BMRA stock was acquired by a variety of institutional investors in the last quarter, including Heritage Investors Management Corp, Virtu Financial LLC, and California Public Employees Retirement System.
View insider buying and selling activity for Biomerica
.

How do I buy shares of Biomerica?

Shares of BMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Biomerica's stock price today?

One share of BMRA stock can currently be purchased for approximately $7.10.

How big of a company is Biomerica?

Biomerica has a market capitalization of $83.45 million and generates $6.69 million in revenue each year. The company earns $-2,340,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis. Biomerica employs 54 workers across the globe.

What is Biomerica's official website?

The official website for Biomerica is www.biomerica.com.

How can I contact Biomerica?

Biomerica's mailing address is 17571 Von Karman Avenue, Irvine CA, 92614. The company can be reached via phone at 949-645-2111.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.